2022
DOI: 10.1016/j.leukres.2021.106756
|View full text |Cite
|
Sign up to set email alerts
|

A national Danish proof of concept on feasibility and safety of home -based intensive chemotherapy in patients with acute myeloid leukemia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 30 publications
0
3
0
Order By: Relevance
“…12 Results from recent pilot studies suggested that outpatient induction chemotherapy in acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS) is feasible without compromising patient safety, provided that appropriate support systems are in place. 13 , 14 Pragmatic solutions like this could also be applied in clinical trials to deliver as much experimental therapy as possible near to home.…”
Section: Working Toward Decentralized Trial Designsmentioning
confidence: 99%
See 1 more Smart Citation
“…12 Results from recent pilot studies suggested that outpatient induction chemotherapy in acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS) is feasible without compromising patient safety, provided that appropriate support systems are in place. 13 , 14 Pragmatic solutions like this could also be applied in clinical trials to deliver as much experimental therapy as possible near to home.…”
Section: Working Toward Decentralized Trial Designsmentioning
confidence: 99%
“…Thus, a decentralized trial design will require substantial training efforts of local staff and close oversight by the investigator, who retains final responsibility for noncompliance in relation to tasks delegated to third parties at a decentralized trial site 12 . Results from recent pilot studies suggested that outpatient induction chemotherapy in acute myeloid leukemia (AML) and high‐risk myelodysplastic syndrome (MDS) is feasible without compromising patient safety, provided that appropriate support systems are in place 13,14 . Pragmatic solutions like this could also be applied in clinical trials to deliver as much experimental therapy as possible near to home.…”
Section: Working Toward Decentralized Trial Designsmentioning
confidence: 99%
“…One department had administered only 5-FU chemotherapy using an elastomeric infusion pump. The other two departments provided multiple chemotherapies and hydrations as home care using an electronic PIP [ 39 , 40 ]. Organizational changes imposed on the two departments, i.e., moving inpatient care to home care managed by the outpatient ambulatory unit, significantly influenced care routines.…”
Section: Development Of the Interventionmentioning
confidence: 99%